Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$101.21 - $166.61 $202 - $333
2 Added 5.41%
39 $4,000
Q4 2023

Feb 29, 2024

SELL
$69.51 - $104.43 $7,993 - $12,009
-115 Reduced 75.66%
37 $3,000
Q4 2023

Feb 22, 2024

BUY
$69.51 - $104.43 $10,565 - $15,873
152 New
152 $15,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.